VIRC
name pending profile ingest
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 33 | -4 | 2.99M | $18.36M | +6 | −10 |
| Q1 2026 | 38 | -3 | 3.87M | $23.69M | +2 | −5 |
| Q4 2025 | 41 | -1 | 4.13M | $26.39M | n/a | −1 |
| Q3 2025 | 13 | +1 | 2.32M | $17.99M | +1 | n/a |
| Q2 2025 | 9 | -1 | 2.38M | $18.99M | n/a | −1 |
| Q1 2025 | 7 | -1 | 1.21M | $11.44M | +1 | −2 |
| Q4 2024 | 8 | 0 | 1.38M | $14.14M | +1 | −1 |
| Q3 2024 | 7 | 0 | 1.28M | $17.75M | +1 | −1 |
| Q2 2024 | 7 | n/a | 985.47K | $13.74M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Renaissance Technologies ✦ | 399.13K | n/a | $5.56M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 234.13K | n/a | $3.26M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 3 | Millennium Management ✦ | 152.64K | n/a | $2.13M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Citadel Advisors ✦ | 82.96K | n/a | $1.16M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 5 | Marshall Wace ✦ | 65.69K | n/a | $915,677 | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Two Sigma Investments ✦ | 28.23K | n/a | $393,470 | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Arrowstreet Capital ✦ | 22.69K | n/a | $316,000 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 72 holders, 6.47M shares, $35.98M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
Officer, Director · Executive Vice… · 3.00K sh @ 6.10 · $18,300
Open-market sales (S)
No open-market insider sales in our coverage window.
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology